Landscapes / Companies
Corregene Biotechnology Co., Ltd not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 1
Drugs
4
in active trials · 5 in all
Trials
4 active
5 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | 31 Dec 2027Phase 1 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Cervical Cancer, Anal Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Nov 2028Phase 1 trial completes | |||
| Next date | 30 Nov 2028 · Phase 1 trial completes | ||||
| Also tested for | Colorectal, Pancreatic and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Dec 2029Phase 1 trial completes | |||
| Next date | 30 Dec 2029 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Mar 2030Phase 1 trial completes | |||
| Next date | 30 Mar 2030 · Phase 1 trial completes | ||||
| Also tested for | Lung Cancer (Locally Advanced or Metastatic), Esophagus Cancer and 2 more | ||||
| Open drug page | |||||
About
- No active trial
- Interleukin-2
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021